Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

S-28679, a new interferon biosynthesis inducer from 3M

April 12, 1996

L-742728 selected by Merck & Co. for further evaluation

April 12, 1996

HGH delivery agents reported by Emisphere Technologies

April 5, 1996

Provir to enter phase II soon

April 5, 1996

SB-214857 in preclinical studies

April 5, 1996

New endothelin antagonists from RPR reported at 211th ACS

April 5, 1996

New agent for sudden cardiac death in phase I at Nortran

April 5, 1996

Another antioxidant from Oxis: TX-153

April 5, 1996

BXT-51072 in line for clinical evaluation at Oxis

April 5, 1996

Novel vasoprotectants in AtheroGenics' pipeline

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...